• [1]
    Mercenier, A., Pavan, S., Pot, B. (2002) Probiotics as biotherapeutic agents: present knowledge and future prospects. Curr. Pharmaceut. Design 8, 99110.
  • [2]
    Cross, M.L. (2002) Microbes versus microbes: immune signals generated by probiotic lactobacilli and their role in protection against microbial pathogens. FEMS Immunol. Med. Microbiol 34, 245253.
  • [3]
    Cross, M.L. (2002) Immunoregulation by probiotic lactobacilli: pro-Th1 signals and their relevance to human health. Clin. Appl. Immunol. Rev 3, 115125.
  • [4]
    Ibnou-Zekri, N., Blum, S., Schiffrin, E.J., von Der Weid, T. (2003) Divergent patterns of colonization and immune response elicited from two intestinal lactobacillus strains that display similar properties in vitro. Infect. Immunol 71, 428436.
  • [5]
    Gill, H.S., Rutherfurd, K.J. (2001) Viability and dose-response studies on the effects of the immunoenhancing lactic acid bacterium Lactobacillus rhamnosus in mice. Br. J. Nutr 86, 285289.
  • [6]
    Donnet-Hughes, A., Rochat, F., Serrant, P., Aeschlimann, J.M., Schiffrin, E.J. (1999) Modulation of nonspecific mechanisms of defense by lactic acid bacteria: effective dose. J. Dairy Sci 82, 863869.
  • [7]
    Kato, I., Tanaka, K., Yokokura, T. (1999) Lactic acid bacterium potently induces the production of interleukin-12 and interferon-gamma by mouse splenocytes. Int. J. Immunopharmacol 21, 121131.
  • [8]
    Hori, T., Kiyoshima, J., Yasui, H. (2003) Effect of an oral administration of Lactobacillus casei strain Shirota on the natural killer activity of blood mononuclear cells in aged mice. Biosci. Biotechnol. Biochem 67, 420422.
  • [9]
    Hori, T., Kiyoshima, J., Shida, K., Yasui, H. (2002) Augmentation of cellular immunity and reduction of influenza virus titer in aged mice fed Lactobacillus casei strain Shirota. Clin. Diagn. Lab Immunol 9, 105108.
  • [10]
    Takagi, A., Matsuzaki, T., Sato, M., Nomoto, K., Morotomi, M., Yokokura, T. (1999) Inhibitory effect of oral administration of Lactobacillus casei on 3 methylcholanthrene-induced carcinogenesis in mice. Med. Microbiol. Immunol 188, 111116.
  • [11]
    Kruis, W., Schutz, E., Fric, P., Fixa, B., Judmaier, G., Stolte, M. (1997) Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol. Ther 11, 853858.
  • [12]
    Vancikova, Z., Lodinova-Zadnikova, R., Radl, J., Tlaskalova-Hogenova, H. (2003) The early postnatal development of salivary antibody and immunoglobulin response in children orally colonized with a nonpathogenic, probiotic strain of E. coli. Folia Microbiol 48, 281287.
  • [13]
    Hockertz, S. (1991) Immunomodulating effect of killed, apathogenic Escherichia coli, strain Nissle 1917, on the macrophage system. Arzneimittelforschung 41, 11081112.
  • [14]
    Hockertz, S. (1997) Augmentation of host defence against bacterial and fungal infections of mice pretreated with the non-pathogenic Escherichia coli strain Nissle 1917. Arzneimittelforschung 47, 793796.
  • [15]
    Lammers, K.M., Helwig, U., Swennen, E., Rizzello, F., Venturi, A., Caramelli, E., Kamm, M.A., Brigidi, P., Gionchetti, P., Campieri, M. (2002) Effect of probiotic strains on interleukin 8 production by HT29/19A cells. Am. J. Gastroenterol 97, 11821186.
    Direct Link:
  • [16]
    Rembacken, B.J., Snelling, A.M., Hawkey, P.M., Chalmers, D.M., Axon, A.T. (1999) Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 354 (9179), 635639.
  • [17]
    Malchow, H.A. (1997) Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease J. Clin. Gastroenterol 25, 653658.
  • [18]
    Heumann, D., Barras, C., Severin, A., Glauser, M.P., Tomasz, A. (1994) Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infect. Immun 62, 27152721.
  • [19]
    Lammers, K.M., Brigidi, P., Vitali, B., Gionchetti, P., Rizzello, F., Caramelli, E., Matteuzzi, D., Campieri, M. (2003) Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunol. Med. Microbiol 38, 165172.
  • [20]
    Cross, M.L., Stevenson, L.M., Gill, H.S. (2001) Anti-allergy properties of fermented foods: an important immunoregulatory mechanism of lactic acid bacteria. Int. Immunopharmacol 1, 891901.
  • [21]
    Miettinen, M., Lehtonen, A., Julkunen, I., Matikainen, S. (2000) Lactobacilli and streptococci activate NF-kB and STAT signaling pathways in human macrophages. J. Immunol 164, 37333740.
  • [22]
    Christensen, H.R., Frokiaer, H., Pestka, J.J. (2002) Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol 168, 171178.
  • [23]
    Morita, H., He, F., Fuse, T., Ouwehand, A.C., Hashimoto, H., Hosoda, M., Mizumachi, K., Kurisaki, J. (2002) Cytokine production by the murine macrophage cell line J774.1 after exposure to lactobacilli. Biosci. Biotechnol. Biochem 66, 19631966.
  • [24]
    Paludan, S.R. (2000) Synergistic action of pro-inflammatory agents: cellular and molecular aspects. J. Leuk. Biol 67, 1825.
  • [25]
    Marin, M.L., Tejada-Simon, M.V., Lee, J.H., Murtha, J., Ustunol, Z., Pestka, J.J. (1998) Stimulation of cytokine production in clonal macrophage and T-cell models by Streptococcus thermophilus: comparison with Bifidobacterium sp. and Lactobacillus bulgaricus. J. Food Prot 61, 859864.
  • [26]
    Miettinen, M., Matikeinen, S., Vuopio-Varkila, J., Pirhonen, J., Varkila, K., Kurimoto, M., Julkunen, I. (1999) Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18 and gamma-interferon production in human peripheral blood mononuclear cells. Infect. Immun 66, 60586062.
  • [27]
    Shida, K., Makino, K., Morishita, A., Takamizawa, K., Hachimura, S., Ametani, A., Sato, T., Kumagai, Y., Habu, S., Kaminogawa, S. (1998) Lactobacillus casei inhibits antigen-induced IgE secretion through regulation of cytokine production in murine splenocyte cultures. Int. Arch. Allerg. Immunol 115, 278287.
  • [28]
    Cross, M.L., Mortensen, R., Kudsk, J., Gill, H.S. (2002) Dietary intake of Lactobacillus rhamnosus HN001 enhances production of both Th1 and Th2 cytokines in antigen-primed mice. Med. Microbiol. Immunol 191, 4953.
  • [29]
    Miettinen, M., Vuopio-Varkila, J., Varkila, K. (1996) Production of human tumour necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect. Immun 64, 54035405.
  • [30]
    Hessle, C., Andersson, B., Wold, A.E. (2000) Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while gram-negative bacteria preferentially stimulate IL-10 production. Infect. Immun 68, 35813586.
  • [31]
    Matsuzaki, T., Yamazaki, R., Hashimoto, S., Yokokura, T. (1998) The effect of oral feeding of Lactobacillus casei strain Shirota on immunoglobulin E production in mice. J. Dairy Sci 81, 4853.
  • [32]
    De Waard, R., Garssen, J., Bokken, G.C., Vos, J.G. (2002) Antagonistic activity of Lactobacillus casei strain Shirota against gastrointestinal Listeria monocytogenes infection in rats. Int. J. Food Microbiol 73, 93100.
  • [33]
    von Der Weid, T., Bulliard, C., Schiffrin, E.J. (2001) Induction by a lactic acid bacterium of a population of CD4+ T cells with low proliferative capacity that produce transforming growth factor beta and interleukin-10. Clin. Diagn. Lab Immunol 8, 695701.
  • [34]
    Chomarat, P., Rissoan, M.C., Banchereau, J., Miossec, P. (1993) Interferon gamma inhibits interleukin10 production by monocytes. J. Exp. Med 177, 523527.
  • [35]
    Haller, D., Bode, C., Hammes, W.P., Pfeifer, A.M., Schiffrin, E.J., Blum, S. (2000) Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Gut 47, 7987.
  • [36]
    He, F., Morita, H., Ouwehand, A.C., Hosoda, M., Hiramatsu, M., Kurisaki, J., Isolauri, E., Benno, Y., Salminen, S. (2002) Stimulation of the secretion of pro-inflammatory cytokines by Bifidobacterium strains. Microbiol. Immunol 46, 781785.
  • [37]
    De Waard, R., Claassen, E., Bokken, G.C., Buiting, B., Garssen, J., Vos, J.G. (2003) Enhanced immunological memory responses to Listeria monocytogenes in rodents, as measured by delayed-type hypersensitivity (DTH), adoptive transfer of DTH, and protective immunity, following Lactobacillus casei Shirota ingestion. Clin. Diagn. Lab Immunol 10, 5965.
  • [38]
    Vidal, K., Donnet-Hughes, A., Granato, D. (2002) Lipoteichoic acids from Lactobacillus johnsonii Strain La1 and Lactobacillus acidophilus Strain La10 antagonize the responsiveness of human intestinal epithelial HT29 cells to lipopolysaccharide and gram-negative bacteria. Infect. Immun 70, 20572064.